secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001104659-23-097790
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents CFO Alexander D'Amico resigns weeks after appointment
------------------------------------------------------------------

- Alexander D'Amico resigned as CFO effective August 28, 2023 under mutual termination agreement.
- D'Amico was appointed on July 10, 2023 (effective August 7, 2023) and served less than a month.
- No severance payments or equity vesting; mutual non-disparagement and release provisions apply.
- Kathleen Bloch continues as Interim CFO under existing consulting arrangement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923097790/0001104659-23-097790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923097790/tm2325277d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-097790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer